Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSW
6426
CSW Industrials
CSW
$5.62B
| $1.24M | ﹤0.01% |
12,031
+4,054
| +51% | +$432K |
|
6427
CALL
eHealth
EHTH
$39.1M
| $1.24M | ﹤0.01% |
132,800
+24,900
| +23% | +$253K |
|
|
GTLS
6428
PUT
DELISTED
Chart Industries
GTLS
| $1.24M | ﹤0.01% |
7,400
-100
| -1% | -$17.1K |
|
6429
PUT
Nkarta
NKTX
$167M
| $1.24M | ﹤0.01% |
100,600
+67,300
| +202% | +$883K |
|
6430
Alector
ALEC
$219M
| $1.24M | ﹤0.01% |
121,877
+16,934
| +16% | +$169K |
|
|
BLD
6431
CALL
DELISTED
TopBuild
BLD
| $1.24M | ﹤0.01% |
7,400
+5,700
| +335% | +$1.04M |
|
|
MAXN
6432
DELISTED
Maxeon Solar Technologies
MAXN
| $1.24M | ﹤0.01% |
930
+2
| +0.2% | +$2.48K |
|
6433
PUT
Natural Resource Partners
NRP
$1.39B
| $1.24M | ﹤0.01% |
33,200
-123,200
| -79% | -$5.59M |
|
|
ROCC
6434
PUT
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.24M | ﹤0.01% |
37,600
+15,400
| +69% | +$580K |
|
6435
PUT
Lindsay Corp
LNN
$1.17B
| $1.24M | ﹤0.01% |
9,300
+2,500
| +37% | +$331K |
|
6436
EnerSys
ENS
$7.3B
| $1.23M | ﹤0.01% |
20,900
+12,303
| +143% | +$811K |
|
6437
Inspired Entertainment
INSE
$164M
| $1.23M | ﹤0.01% |
143,142
+81,028
| +130% | +$826K |
|
6438
CALL
Tower Semiconductor
TSEM
$29.8B
| $1.23M | ﹤0.01% |
26,700
-64,200
| -71% | -$3.06M |
|
6439
PUT
Weibo
WB
$1.86B
| $1.23M | ﹤0.01% |
53,300
-9,300
| -15% | -$208K |
|
6440
PUT
Blue Owl Capital
OWL
$18.2B
| $1.23M | ﹤0.01% |
122,800
+19,000
| +18% | +$228K |
|
6441
Expro Ltd
XPRO
$2.1B
| $1.23M | ﹤0.01% |
106,889
+44,875
| +72% | +$641K |
|
6442
CALL
Prothena Corp
PRTA
$455M
| $1.23M | ﹤0.01% |
45,300
+600
| +1% | +$17.6K |
|
6443
CALL
Prospect Capital
PSEC
$1.11B
| $1.23M | ﹤0.01% |
176,000
+103,000
| +141% | +$791K |
|
6444
PUT
Ameren
AEE
$30.4B
| $1.23M | ﹤0.01% |
13,600
-36,800
| -73% | -$3.41M |
|
6445
CALL
Chord Energy
CHRD
$7.82B
| $1.23M | ﹤0.01% |
10,100
-15,500
| -61% | -$2.27M |
|
6446
PUT
Vanguard Total World Stock ETF
VT
$81.6B
| $1.23M | ﹤0.01% |
14,400
-47,700
| -77% | -$4.41M |
|
6447
PUT
Renaissance IPO ETF
IPO
$159M
| $1.23M | ﹤0.01% |
40,800
-100,300
| -71% | -$3.39M |
|
6448
PUT
Ascendis Pharma A/S
ASND
$16.3B
| $1.23M | ﹤0.01% |
13,200
-26,300
| -67% | -$2.48M |
|
6449
PUT
Infosys
INFY
$47.1B
| $1.23M | ﹤0.01% |
66,300
-36,100
| -35% | -$718K |
|
6450
PUT
Progyny
PGNY
$2.02B
| $1.23M | ﹤0.01% |
42,200
+18,300
| +77% | +$655K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.